MX370502B - Rotavirus humanos modificados y usos para estos. - Google Patents
Rotavirus humanos modificados y usos para estos.Info
- Publication number
- MX370502B MX370502B MX2015002495A MX2015002495A MX370502B MX 370502 B MX370502 B MX 370502B MX 2015002495 A MX2015002495 A MX 2015002495A MX 2015002495 A MX2015002495 A MX 2015002495A MX 370502 B MX370502 B MX 370502B
- Authority
- MX
- Mexico
- Prior art keywords
- modified human
- uses therefor
- present disclosure
- human rotaviruses
- rotaviruses
- Prior art date
Links
- 241000617996 Human rotavirus Species 0.000 title abstract 2
- 229940124859 Rotavirus vaccine Drugs 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21004—Trypsin (3.4.21.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12361—Methods of inactivation or attenuation
- C12N2720/12363—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12361—Methods of inactivation or attenuation
- C12N2720/12364—Methods of inactivation or attenuation by serial passage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere generalmente al campo de las vacunas víricas. Concretamente, la presente divulgación proporciona una cepa de rotavirus humano adaptado a Vero modificado y un método de cultivo para producir una concentración de virus elevado, una vacuna de rotavirus, protocolos de vacunación y ensayos de diagnóstico y pronóstico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2012903702A AU2012903702A0 (en) | 2012-08-27 | Modified human rotaviruses and uses therefor | |
PCT/AU2013/000945 WO2014032082A1 (en) | 2012-08-27 | 2013-08-26 | Modified human rotaviruses and uses therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015002495A MX2015002495A (es) | 2016-06-30 |
MX370502B true MX370502B (es) | 2019-12-16 |
Family
ID=50182243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015002495A MX370502B (es) | 2012-08-27 | 2013-08-26 | Rotavirus humanos modificados y usos para estos. |
Country Status (11)
Country | Link |
---|---|
US (2) | US9969985B2 (es) |
EP (1) | EP2888355B1 (es) |
KR (1) | KR102182186B1 (es) |
CN (1) | CN104812892B (es) |
AU (1) | AU2013308377B2 (es) |
BR (1) | BR112015004085A2 (es) |
CU (1) | CU24328B1 (es) |
IN (1) | IN2015DN01342A (es) |
MX (1) | MX370502B (es) |
NZ (1) | NZ631348A (es) |
WO (1) | WO2014032082A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201900250D0 (en) | 2019-01-08 | 2019-02-27 | Ge Healthcare Bio Sciences Ab | Method for virus propagation |
CN117947096A (zh) * | 2024-01-16 | 2024-04-30 | 伊诺维康(北京)生物科技有限公司 | 一种羊轮状病毒重组质粒、反向遗传病毒学拯救系统及其构建方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4579945A (en) | 1982-04-29 | 1986-04-01 | Ribi Immunochem Research, Inc. | Purification of trehalose dimycolates |
US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
US6056957A (en) | 1994-08-04 | 2000-05-02 | Schering Corporation | Humanized monoclonal antibodies against human interleukin-5 |
GB9919468D0 (en) * | 1999-08-17 | 1999-10-20 | Smithkline Beecham Biolog | Vaccine |
EA005952B1 (ru) * | 1999-08-17 | 2005-08-25 | Смитклайн Бичем Байолоджикалз С.А. | Ослабленная популяция ротавирусов и содержащая ее вакцинная композиция |
US9642907B2 (en) * | 2006-05-12 | 2017-05-09 | Bharat Biotech International Limited | Stabilized liquid rotavirus vaccine composition |
EP2429577B1 (en) * | 2009-05-12 | 2019-01-30 | The Government of The United States of America, as represented by the Secretary, Department of Health and Human Services, | New human rotavirus strains and vaccines |
-
2013
- 2013-08-26 IN IN1342DEN2015 patent/IN2015DN01342A/en unknown
- 2013-08-26 AU AU2013308377A patent/AU2013308377B2/en active Active
- 2013-08-26 KR KR1020157007160A patent/KR102182186B1/ko active IP Right Grant
- 2013-08-26 CU CUP2015000019A patent/CU24328B1/es unknown
- 2013-08-26 MX MX2015002495A patent/MX370502B/es active IP Right Grant
- 2013-08-26 US US14/423,660 patent/US9969985B2/en active Active
- 2013-08-26 CN CN201380054966.7A patent/CN104812892B/zh active Active
- 2013-08-26 EP EP13833197.0A patent/EP2888355B1/en active Active
- 2013-08-26 NZ NZ631348A patent/NZ631348A/en not_active IP Right Cessation
- 2013-08-26 WO PCT/AU2013/000945 patent/WO2014032082A1/en active Application Filing
- 2013-08-26 BR BR112015004085A patent/BR112015004085A2/pt not_active Application Discontinuation
-
2018
- 2018-04-06 US US15/947,649 patent/US20180346884A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN104812892B (zh) | 2018-07-17 |
BR112015004085A2 (pt) | 2017-08-08 |
US20150337268A1 (en) | 2015-11-26 |
AU2013308377B2 (en) | 2019-06-06 |
CU24328B1 (es) | 2018-03-13 |
US20180346884A1 (en) | 2018-12-06 |
KR20150044954A (ko) | 2015-04-27 |
IN2015DN01342A (es) | 2015-07-03 |
EP2888355A4 (en) | 2016-08-10 |
CU20150019A7 (es) | 2015-09-29 |
AU2013308377A1 (en) | 2015-02-26 |
WO2014032082A8 (en) | 2015-04-16 |
NZ631348A (en) | 2017-02-24 |
WO2014032082A1 (en) | 2014-03-06 |
EP2888355A1 (en) | 2015-07-01 |
MX2015002495A (es) | 2016-06-30 |
KR102182186B1 (ko) | 2020-11-25 |
US9969985B2 (en) | 2018-05-15 |
EP2888355B1 (en) | 2020-06-17 |
CN104812892A (zh) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501602A1 (en) | Subunit immersion vaccines for fish | |
PH12017500727A1 (en) | Modified virus-like particles of cmv | |
MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
EA201300915A1 (ru) | Новый европейский штамм prrsv | |
MX346245B (es) | Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria. | |
EP2836230A4 (en) | ANTIGENS FILOVIRUS CONSENSUS, NUCLEIC ACID CONSTRUCTS AND VACCINES THEREOF, AND METHODS OF USE THEREOF | |
MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
EP2836505A4 (en) | HUMAN RESPIRATORY SYNZYTIALVIRUS CONSENSUS ANTIGENES, NUCLEIC ACIDIC CONSTRUCTS AND VACCINES THEREOF AND METHOD OF USE THEREOF | |
PH12016500500A1 (en) | A viral vaccine and methods of manufacture thereof | |
NZ603863A (en) | Concentration and lyophilization of influenza vaccine antigens | |
BR112014001049A2 (pt) | método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral | |
IN2014KN02769A (es) | ||
MX2013015198A (es) | Vacuna del corona virus canino. | |
NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
WO2016210083A3 (en) | Inactivated canine influenza vaccines and methods of making and uses thereof | |
IN2015DN02335A (es) | ||
MX370502B (es) | Rotavirus humanos modificados y usos para estos. | |
EP3599247A3 (en) | Recombinant hemagglutinin protein of influenza virus and vaccine containing the same | |
CL2013001219A1 (es) | Metodo para producir virus monoglucosilado de influenza; virus monoglucosilado del antígeno de influenza ha (virus completo o recombinante); uso del virus para preparar vacuna. | |
WO2014008475A3 (en) | Compositions and methods related to viral vaccines | |
PL2855513T3 (pl) | Szczepionka przeciwko wirusowi Schmallenberg (SBV), sposoby wytwarzania i jej zastosowanie | |
WO2013173256A3 (en) | New and improved influenza vaccines | |
MX2015007195A (es) | Preparacion de vacunas vivas. | |
PL406631A1 (pl) | Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie | |
UA59897U (ru) | Способ изготовления вакцины против бешенства животных "рабизин" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |